These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22205345)

  • 61. Tuft-shaped astrocytes in Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
    Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
    Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E
    PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?
    Frigerio R; Fujishiro H; Ahn TB; Josephs KA; Maraganore DM; DelleDonne A; Parisi JE; Klos KJ; Boeve BF; Dickson DW; Ahlskog JE
    Neurobiol Aging; 2011 May; 32(5):857-63. PubMed ID: 19560232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.
    Lee HJ; Bae EJ; Lee SJ
    Nat Rev Neurol; 2014 Feb; 10(2):92-8. PubMed ID: 24468877
    [TBL] [Abstract][Full Text] [Related]  

  • 67. α-synuclein phosphorylation and truncation are normal events in the adult human brain.
    Muntané G; Ferrer I; Martinez-Vicente M
    Neuroscience; 2012 Jan; 200():106-19. PubMed ID: 22079575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
    Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
    Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
    Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
    Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies.
    Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
    Brain Res Mol Brain Res; 2004 Nov; 131(1-2):131-5. PubMed ID: 15530662
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significance of brain lesions in Parkinson disease dementia and Lewy body dementia.
    Jellinger KA
    Front Neurol Neurosci; 2009; 24():114-125. PubMed ID: 19182469
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies.
    Higashi S; Moore DJ; Minegishi M; Kasanuki K; Fujishiro H; Kabuta T; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H; Wada K; Iseki E
    J Neuropathol Exp Neurol; 2011 Apr; 70(4):264-80. PubMed ID: 21412173
    [TBL] [Abstract][Full Text] [Related]  

  • 76. LRRK2 variation and dementia with Lewy bodies.
    Heckman MG; Soto-Ortolaza AI; Contreras MYS; Murray ME; Pedraza O; Diehl NN; Walton R; Labbé C; Lorenzo-Betancor O; Uitti RJ; van Gerpen J; Ertekin-Taner N; Smith GE; Kantarci K; Savica R; Jones DT; Graff-Radford J; Knopman DS; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Rademakers R; Wszolek ZK; Graff-Radford NR; Ferman TJ; Dickson DW; Boeve BF; Ross OA
    Parkinsonism Relat Disord; 2016 Oct; 31():98-103. PubMed ID: 27521182
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methylation changes and aberrant expression of FGFR3 in Lewy body disease neurons.
    Tsuchida T; Mano T; Koshi-Mano K; Bannai T; Matsubara T; Yamashita S; Ushijima T; Nagata K; Murayama S; Toda T; Tsuji S; Iwata A
    Brain Res; 2018 Oct; 1697():59-66. PubMed ID: 29909202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
    Fodero-Tavoletti MT; Smith DP; McLean CA; Adlard PA; Barnham KJ; Foster LE; Leone L; Perez K; Cortés M; Culvenor JG; Li QX; Laughton KM; Rowe CC; Masters CL; Cappai R; Villemagne VL
    J Neurosci; 2007 Sep; 27(39):10365-71. PubMed ID: 17898208
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies.
    Hatton C; Reeve A; Lax NZ; Blain A; Ng YS; El-Agnaf O; Attems J; Taylor JP; Turnbull D; Erskine D
    Acta Neuropathol Commun; 2020 Jul; 8(1):103. PubMed ID: 32646480
    [TBL] [Abstract][Full Text] [Related]  

  • 80. α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration.
    Beyer K; Ariza A
    Mol Neurobiol; 2013 Apr; 47(2):509-24. PubMed ID: 22923347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.